Product Code: TMRGL59688
The report provides revenue of the global sinus dilation devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global sinus dilation devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the sinus dilation devices market.
The report delves into the competitive landscape of the global sinus dilation devices market. Key players operating in the global sinus dilation devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global sinus dilation devices market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sinus Dilation Devices Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Sinus Dilation Devices Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Key Industry Developments
- 5.2. Porter's Five Forces Analysis - Sinus Dilation Devices Market
- 5.3. Chronic Sinusitis - An Overview
- 5.4. Chronic Sinusitis - Prevalence
- 5.5. Regulatory Approval Process
- 5.6. Sinus Dilation Procedures - CPT Codes
- 5.7. COVID-19 Pandemic's Impact on Industry (value chain and short / mid / long term impact)
6. Global Sinus Dilation Devices Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Balloon Sinus Dilation Devices
- 6.3.2. Sinus Stents
- 6.3.3. Endoscopy
- 6.3.3.1. Sinuscopy
- 6.3.3.2. Rhinoscopy
- 6.3.4. FESS Instruments
- 6.3.5. Others
- 6.4. Market Attractiveness Analysis, by Product
7. Global Sinus Dilation Devices Market Analysis and Forecast, by Procedure
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Procedure, 2017-2031
- 7.3.1. Standalone
- 7.3.2. Hybrid
- 7.4. Market Attractiveness Analysis, by Procedure
8. Global Sinus Dilation Devices Market Analysis and Forecast, by Patient Type
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Patient Type, 2017-2031
- 8.3.1. Adult
- 8.3.2. Pediatric
- 8.4. Market Attractiveness Analysis, by Patient Type
9. Global Sinus Dilation Devices Market Analysis and Forecast, by End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. ENT Clinics
- 9.4. Market Attractiveness Analysis, by End-user
10. Global Sinus Dilation Devices Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness Analysis, by Region
11. North America Sinus Dilation Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Balloon Sinus Dilation Devices
- 11.2.2. Sinus Stents
- 11.2.3. Endoscopy
- 11.2.3.1. Sinuscopy
- 11.2.3.2. Rhinoscopy
- 11.2.4. FESS Instruments
- 11.2.5. Others
- 11.3. Market Value Forecast, by Procedure, 2017-2031
- 11.3.1. Standalone
- 11.3.2. Hybrid
- 11.4. Market Value Forecast, by Patient Type, 2017-2031
- 11.4.1. Adult
- 11.4.2. Pediatric
- 11.5. Market Value Forecast, by End-user, 2017-2031
- 11.5.1. Hospitals
- 11.5.2. Ambulatory Surgical Centers
- 11.5.3. ENT Clinics
- 11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Procedure
- 11.7.3. By Patient Type
- 11.7.4. By End-user
- 11.7.5. By Country
12. Europe Sinus Dilation Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Balloon Sinus Dilation Devices
- 12.2.2. Sinus Stents
- 12.2.3. Endoscopy
- 12.2.3.1. Sinuscopy
- 12.2.3.2. Rhinoscopy
- 12.2.4. FESS Instruments
- 12.2.5. Others
- 12.3. Market Value Forecast, by Procedure, 2017-2031
- 12.3.1. Standalone
- 12.3.2. Hybrid
- 12.4. Market Value Forecast, by Patient Type, 2017-2031
- 12.4.1. Adult
- 12.4.2. Pediatric
- 12.5. Market Value Forecast, by End-user, 2017-2031
- 12.5.1. Hospitals
- 12.5.2. Ambulatory Surgical Centers
- 12.5.3. ENT Clinics
- 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Product
- 12.7.2. By Procedure
- 12.7.3. By Patient Type
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region
13. Asia Pacific Sinus Dilation Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Balloon Sinus Dilation Devices
- 13.2.2. Sinus Stents
- 13.2.3. Endoscopy
- 13.2.3.1. Sinuscopy
- 13.2.3.2. Rhinoscopy
- 13.2.4. FESS Instruments
- 13.2.5. Others
- 13.3. Market Value Forecast, by Procedure, 2017-2031
- 13.3.1. Standalone
- 13.3.2. Hybrid
- 13.4. Market Value Forecast, by Patient Type, 2017-2031
- 13.4.1. Adult
- 13.4.2. Pediatric
- 13.5. Market Value Forecast, by End-user, 2017-2031
- 13.5.1. Hospitals
- 13.5.2. Ambulatory Surgical Centers
- 13.5.3. ENT Clinics
- 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Product
- 13.7.2. By Procedure
- 13.7.3. By Patient Type
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region
14. Latin America Sinus Dilation Devices Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Balloon Sinus Dilation Devices
- 14.2.2. Sinus Stents
- 14.2.3. Endoscopy
- 14.2.3.1. Sinuscopy
- 14.2.3.2. Rhinoscopy
- 14.2.4. FESS Instruments
- 14.2.5. Others
- 14.3. Market Value Forecast, by Procedure, 2017-2031
- 14.3.1. Standalone
- 14.3.2. Hybrid
- 14.4. Market Value Forecast, by Patient Type, 2017-2031
- 14.4.1. Adult
- 14.4.2. Pediatric
- 14.5. Market Value Forecast, by End-user, 2017-2031
- 14.5.1. Hospitals
- 14.5.2. Ambulatory Surgical Centers
- 14.5.3. ENT Clinics
- 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Product
- 14.7.2. By Procedure
- 14.7.3. By Patient Type
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region
15. Middle East & Africa Sinus Dilation Devices Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Balloon Sinus Dilation Devices
- 15.2.2. Sinus Stents
- 15.2.3. Endoscopy
- 15.2.3.1. Sinuscopy
- 15.2.3.2. Rhinoscopy
- 15.2.4. FESS Instruments
- 15.2.5. Others
- 15.3. Market Value Forecast, by Procedure, 2017-2031
- 15.3.1. Standalone
- 15.3.2. Hybrid
- 15.4. Market Value Forecast, by Patient Type, 2017-2031
- 15.4.1. Adult
- 15.4.2. Pediatric
- 15.5. Market Value Forecast, by End-user, 2017-2031
- 15.5.1. Hospitals
- 15.5.2. Ambulatory Surgical Centers
- 15.5.3. ENT Clinics
- 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Product
- 15.7.2. By Procedure
- 15.7.3. By Patient Type
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (by tier and size of companies)
- 16.2. Market Share Analysis, by Company, 2021
- 16.3. Company Profiles
- 16.3.1. Medtronic plc
- 16.3.1.1. Company overview
- 16.3.1.2. Financial overview
- 16.3.1.3. Business strategies
- 16.3.1.4. SWOT analysis
- 16.3.1.5. Recent developments
- 16.3.2. Smith & Nephew plc
- 16.3.2.1. Company overview
- 16.3.2.2. Financial overview
- 16.3.2.3. Business strategies
- 16.3.2.4. SWOT analysis
- 16.3.2.5. Recent developments
- 16.3.3. Olympus Corporation
- 16.3.3.1. Company overview
- 16.3.3.2. Financial overview
- 16.3.3.3. Business strategies
- 16.3.3.4. SWOT analysis
- 16.3.3.5. Recent developments
- 16.3.4. KARL STORZ SE & Co. KG.
- 16.3.4.1. Company overview
- 16.3.4.2. Financial overview
- 16.3.4.3. Business strategies
- 16.3.4.4. SWOT analysis
- 16.3.4.5. Recent developments
- 16.3.5. Acclarent, Inc. (Johnson & Johnson)
- 16.3.5.1. Company overview
- 16.3.5.2. Financial overview
- 16.3.5.3. Business strategies
- 16.3.5.4. SWOT analysis
- 16.3.5.5. Recent developments
- 16.3.6. Entellus Medical Inc. (Stryker)
- 16.3.6.1. Company overview
- 16.3.6.2. Financial overview
- 16.3.6.3. Business strategies
- 16.3.6.4. SWOT analysis
- 16.3.6.5. Recent developments
- 16.3.7. Intersect ENT, Inc.
- 16.3.7.1. Company overview
- 16.3.7.2. Financial overview
- 16.3.7.3. Business strategies
- 16.3.7.4. SWOT analysis
- 16.3.7.5. Recent developments
- 16.3.8. SinuSys Corporation
- 16.3.8.1. Company overview
- 16.3.8.2. Financial overview
- 16.3.8.3. Business strategies
- 16.3.8.4. SWOT analysis
- 16.3.8.5. Recent developments
- 16.3.9. Meril Life Sciences Pvt. Ltd.
- 16.3.9.1. Company overview
- 16.3.9.2. Financial overview
- 16.3.9.3. Business strategies
- 16.3.9.4. SWOT analysis
- 16.3.9.5. Recent developments
- 16.3.10. Dalent LLC.
- 16.3.10.1. Company overview
- 16.3.10.2. Financial overview
- 16.3.10.3. Business strategies
- 16.3.10.4. SWOT analysis
- 16.3.10.5. Recent developments